Daewon Pharmaceutical Co., Ltd. (KRX:003220)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cosmetics	30.07B	34.47B	-	-	-
Pharmaceuticals	542.98B	536.09B	500.70B	452.80B	339.08B
Consolidated Adjustments	-4.17B	-958.60M	-521.20M	-1.07B	-155.22M
Other Sectors	481.72M	504.20M	-	-	-
Health Functional Food	36.07B	28.06B	26.48B	25.86B	13.07B
Hearing Aid	-	-	295.28M	1.29B	2.19B
Total	605.43B	598.16B	526.95B	478.88B	354.18B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Foreign	20.68B	31.59B	10.53B	11.71B	10.56B
South Korea	584.75B	566.57B	516.43B	467.17B	343.62B
Total	605.43B	598.16B	526.95B	478.88B	354.18B

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 18, 2026

Data Sources Report a data error